These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
178 related items for PubMed ID: 29046203
1. [Clinical effect of anti-D immunoglobulin in treatment of childhood immune thrombocytopenia: a Meta analysis]. Qin W, Huang SL, Li TT. Zhongguo Dang Dai Er Ke Za Zhi; 2017 Oct; 19(10):1070-1076. PubMed ID: 29046203 [Abstract] [Full Text] [Related]
2. First Line Treatments for Newly Diagnosed Primary Immune Thrombocytopenia in Children: A Systematic Review and Network Meta-analysis. Acero-Garcés DO, García-Perdomo HA. Curr Pediatr Rev; 2020 Oct; 16(1):61-70. PubMed ID: 31656149 [Abstract] [Full Text] [Related]
3. Efficacy and Safety of Anti-D Immunoglobulins versus Intravenous Immunoglobulins for Immune Thrombocytopenia in Children: Systematic Review and Meta-analysis of Randomized Controlled Trials. Lioger B, Maillot F, Ternant D, Passot C, Paintaud G, Bejan-Angoulvant T. J Pediatr; 2019 Jan; 204():225-233.e8. PubMed ID: 30314658 [Abstract] [Full Text] [Related]
4. Intravenous immune globulin versus intravenous anti-D immune globulin for the treatment of acute immune thrombocytopenic purpura. Shahgholi E, Vosough P, Sotoudeh K, Arjomandi K, Ansari S, Salehi S, Faranoush M, Ehsani MA. Indian J Pediatr; 2008 Dec; 75(12):1231-5. PubMed ID: 19190878 [Abstract] [Full Text] [Related]
6. A single dose of anti-D immunoglobulin raises platelet count as efficiently as intravenous immunoglobulin in newly diagnosed immune thrombocytopenic purpura in Korean children. Son DW, Jeon IS, Yang SW, Cho SH. J Pediatr Hematol Oncol; 2008 Aug; 30(8):598-601. PubMed ID: 18799936 [Abstract] [Full Text] [Related]
7. Single dose of anti-D immune globulin at 75 microg/kg is as effective as intravenous immune globulin at rapidly raising the platelet count in newly diagnosed immune thrombocytopenic purpura in children. Tarantino MD, Young G, Bertolone SJ, Kalinyak KA, Shafer FE, Kulkarni R, Weber LC, Davis ML, Lynn H, Nugent DJ, Acute ITP Study Group. J Pediatr; 2006 Apr; 148(4):489-94. PubMed ID: 16647411 [Abstract] [Full Text] [Related]
8. Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura. El Alfy MS, Mokhtar GM, El-Laboudy MA, Khalifa AS. Acta Haematol; 2006 Apr; 115(1-2):46-52. PubMed ID: 16424649 [Abstract] [Full Text] [Related]
9. Treatment of childhood acute immune thrombocytopenic purpura with anti-D immune globulin or pooled immune globulin. Tarantino MD, Madden RM, Fennewald DL, Patel CC, Bertolone SJ. J Pediatr; 1999 Jan; 134(1):21-6. PubMed ID: 9880444 [Abstract] [Full Text] [Related]
12. Comparison of intravenous immune globulin and high dose anti-D immune globulin as initial therapy for childhood immune thrombocytopenic purpura. Kane I, Ragucci D, Shatat IF, Bussel J, Kalpatthi R. Br J Haematol; 2010 Apr; 149(1):79-83. PubMed ID: 20096011 [Abstract] [Full Text] [Related]
13. Standard-dose intravenous anti-D immunoglobulin versus intravenous immunoglobulin in the treatment of newly diagnosed childhood primary immune thrombocytopenia. Papagianni A, Economou M, Tragiannidis A, Karatza E, Tsatra I, Gombakis N, Athanassiadou-Piperopoulou F, Athanasiou-Metaxa M. J Pediatr Hematol Oncol; 2011 May; 33(4):265-9. PubMed ID: 21516022 [Abstract] [Full Text] [Related]
14. Comparison between IV immune globulin (IVIG) and anti-D globulin for treatment of immune thrombocytopenia: a randomized open-label study. Eghbali A, Azadmanesh P, Bagheri B, Taherahmadi H, Sadeghi Sedeh B. Fundam Clin Pharmacol; 2016 Aug; 30(4):385-9. PubMed ID: 26991138 [Abstract] [Full Text] [Related]
15. A comparative study of initial use of intravenous immunoglobulin and prednisolone treatments in childhood idiopathic thrombocytopenic purpur. Ou CY, Hsieh KS, Chiou YH, Chang YH, Ger LP. Acta Paediatr Taiwan; 2006 Aug; 47(5):226-31. PubMed ID: 17352309 [Abstract] [Full Text] [Related]
16. Low-dose versus high-dose immunoglobulin for primary treatment of acute immune thrombocytopenic purpura in children: results of a prospective, randomized single-center trial. Benesch M, Kerbl R, Lackner H, Berghold A, Schwinger W, Triebl-Roth K, Urban C. J Pediatr Hematol Oncol; 2003 Oct; 25(10):797-800. PubMed ID: 14528103 [Abstract] [Full Text] [Related]
17. The efficacy of different dose intravenous immunoglobulin in treating acute idiopathic thrombocytopenic purpura: a meta-analysis of 13 randomized controlled trials. Qin YH, Zhou TB, Su LN, Lei FY, Zhao YJ, Huang WF. Blood Coagul Fibrinolysis; 2010 Dec; 21(8):713-21. PubMed ID: 20962624 [Abstract] [Full Text] [Related]
18. Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura. Blanchette V, Imbach P, Andrew M, Adams M, McMillan J, Wang E, Milner R, Ali K, Barnard D, Bernstein M. Lancet; 1994 Sep 10; 344(8924):703-7. PubMed ID: 7915773 [Abstract] [Full Text] [Related]
19. Canadian cost- utility analysis of intravenous immunoglobulin for acute childhood idiopathic thrombocytopenic purpura. Blackhouse G, Xie F, Levine MA, Campbell K, Assasi N, Gaebel K, O'Reilly D, Tarride J, Goeree R. J Popul Ther Clin Pharmacol; 2012 Sep 10; 19(2):e166-78. PubMed ID: 22580389 [Abstract] [Full Text] [Related]
20. The effect of ABO and Rh blood type on the response to intravenous immune globulin (IVIG) in children with immune thrombocytopenic purpura (ITP). Sturgill MG, Nagabandi SR, Drachtman RA, Ettinger AG, Rubin J, Ettinger LJ. J Pediatr Hematol Oncol; 1997 Sep 10; 19(6):523-5. PubMed ID: 9407938 [Abstract] [Full Text] [Related] Page: [Next] [New Search]